These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Generation of human lymphokine-activated killer cells following brief exposure to high dose interleukin 2. Horton SA, Oldham RK, Yannelli JR. Cancer Res; 1990 Mar 15; 50(6):1686-92. PubMed ID: 2306722 [Abstract] [Full Text] [Related]
3. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid. Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY. J Soc Gynecol Investig; 1995 Mar 15; 2(6):762-71. PubMed ID: 9420887 [Abstract] [Full Text] [Related]
4. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4. Keever CA, Pekle K, Gazzola MV, Collins NH, Bourhis JH, Gillio A. J Immunol; 1989 Nov 15; 143(10):3241-9. PubMed ID: 2809200 [Abstract] [Full Text] [Related]
5. Induction of natural killer cell activity and perforin and granzyme B gene expression following continuous culture of short pulse with interleukin-12 in young and old mice. Argentati K, Bartozzi B, Bernardini G, Di Stasio G, Provinciali M. Eur Cytokine Netw; 2000 Mar 15; 11(1):59-66. PubMed ID: 10705300 [Abstract] [Full Text] [Related]
6. Phenotypic and cell cycle analysis of human peripheral blood mononuclear cells activated with interleukin-2 and/or OKT3. Platts KE, Lawry J, Hancock BW, Rees RC. Exp Cell Res; 1993 Sep 15; 208(1):154-60. PubMed ID: 8359215 [Abstract] [Full Text] [Related]
13. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer. Stewart JA, Belinson JL, Moore AL, Dorighi JA, Grant BW, Haugh LD, Roberts JD, Albertini RJ, Branda RF. Cancer Res; 1990 Oct 01; 50(19):6302-10. PubMed ID: 2205379 [Abstract] [Full Text] [Related]
14. Human monocytes inhibit lymphokine-activated killer cell expansion in vitro. Triozzi PL, Aldrich WA, Rinehart JJ. Mol Biother; 1991 Mar 01; 3(1):22-5. PubMed ID: 2069757 [Abstract] [Full Text] [Related]
17. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S. J Clin Lab Immunol; 1993 Mar 01; 40(2):47-60. PubMed ID: 7932628 [Abstract] [Full Text] [Related]